Boston Advisors LLC increased its position in shares of Hill-Rom Holdings Inc (NYSE:HRC) by 14.3% during the second quarter, Holdings Channel reports. The firm owned 242,554 shares of the medical technology company’s stock after buying an additional 30,344 shares during the period. Boston Advisors LLC’s holdings in Hill-Rom Holdings were worth $19,310,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. Shell Asset Management Co. bought a new position in Hill-Rom Holdings during the first quarter worth $1,088,000. Sawgrass Asset Management LLC bought a new position in Hill-Rom Holdings during the first quarter worth $428,000. First Quadrant L P CA raised its position in Hill-Rom Holdings by 277.1% in the first quarter. First Quadrant L P CA now owns 46,380 shares of the medical technology company’s stock worth $3,274,000 after buying an additional 34,080 shares during the period. Acadian Asset Management LLC raised its position in Hill-Rom Holdings by 2.6% in the first quarter. Acadian Asset Management LLC now owns 140,072 shares of the medical technology company’s stock worth $9,889,000 after buying an additional 3,505 shares during the period. Finally, BTIM Corp. bought a new position in Hill-Rom Holdings during the first quarter worth $14,935,000. 83.81% of the stock is owned by institutional investors.

Shares of Hill-Rom Holdings Inc (NYSE HRC) opened at 79.70 on Friday. The stock has a market capitalization of $5.24 billion, a P/E ratio of 34.43 and a beta of 1.23. The firm’s 50-day moving average price is $80.93 and its 200 day moving average price is $71.62. Hill-Rom Holdings Inc has a 52 week low of $50.50 and a 52 week high of $84.65.

Hill-Rom Holdings (NYSE:HRC) last issued its quarterly earnings results on Friday, April 28th. The medical technology company reported $0.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.79 by $0.09. The business had revenue of $678.90 million for the quarter, compared to the consensus estimate of $654.27 million. Hill-Rom Holdings had a return on equity of 19.77% and a net margin of 5.80%. The business’s quarterly revenue was up 7.3% on a year-over-year basis. During the same period in the prior year, the firm posted $0.71 earnings per share. Analysts expect that Hill-Rom Holdings Inc will post $3.86 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 29th. Stockholders of record on Friday, September 15th will be given a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.90%. The ex-dividend date of this dividend is Thursday, September 14th. Hill-Rom Holdings’s payout ratio is presently 31.03%.

ILLEGAL ACTIVITY NOTICE: “Boston Advisors LLC Has $19.31 Million Position in Hill-Rom Holdings Inc (NYSE:HRC)” was originally published by Daily Political and is the property of of Daily Political. If you are viewing this piece on another publication, it was copied illegally and republished in violation of US and international trademark & copyright legislation. The original version of this piece can be read at https://www.dailypolitical.com/2017/07/28/boston-advisors-llc-has-19-31-million-position-in-hill-rom-holdings-inc-nysehrc.html.

A number of research analysts recently weighed in on the company. BidaskClub lowered Hill-Rom Holdings from a “strong-buy” rating to a “buy” rating in a research report on Monday. Zacks Investment Research lowered Hill-Rom Holdings from a “buy” rating to a “hold” rating in a research report on Tuesday, July 11th. Barclays PLC raised their price objective on Hill-Rom Holdings from $80.00 to $86.00 and gave the company an “overweight” rating in a research report on Friday, June 9th. Cantor Fitzgerald assumed coverage on Hill-Rom Holdings in a research report on Thursday, June 29th. They set a “neutral” rating and a $86.00 price objective for the company. Finally, Needham & Company LLC assumed coverage on Hill-Rom Holdings in a research report on Thursday, June 29th. They set a “buy” rating and a $95.00 price objective for the company. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Hill-Rom Holdings presently has a consensus rating of “Buy” and an average price target of $88.50.

In other news, SVP Andreas G. Frank sold 10,660 shares of the company’s stock in a transaction on Tuesday, June 6th. The stock was sold at an average price of $78.62, for a total transaction of $838,089.20. Following the transaction, the senior vice president now directly owns 28,988 shares of the company’s stock, valued at $2,279,036.56. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, SVP Paul Sherwood Johnson sold 2,078 shares of the company’s stock in a transaction on Wednesday, May 17th. The stock was sold at an average price of $72.30, for a total value of $150,239.40. The disclosure for this sale can be found here. Corporate insiders own 2.20% of the company’s stock.

Hill-Rom Holdings Company Profile

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings Inc (NYSE:HRC).

Institutional Ownership by Quarter for Hill-Rom Holdings (NYSE:HRC)

Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.